Delivery Order SPE2DB20D2104-SPE2DB23FT71F
- Not listed
- This federal contract award, valued at $1,298.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 60 capsules of the drug Lubiprostone 24 MCG, with a completion date of November 12, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 24 MCG Capsule 60S. The contract is a firm fixed price delivery order with a ceiling value of $2,042.65 and has a performance period through November 21, 2022. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lubiprostone 24 MCG Capsule 60s. The contract has a ceiling value of $1,299.26 and is a Firm Fixed Price Delivery Order. There was no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lubiprostone 24 MCG Capsule 60S, a pharmaceutical product. The $3,999.85 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 5, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lubiprostone 24 MCG Capsules. The $2,891.20 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 25, 2021. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC enables the DLA to efficiently...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a $10,784.78 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4557714344 - LUBIPROSTONE 8 MCG CAPSULE 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 8 MCG Capsules. The $1,358.73 firm fixed-price contract has an ultimate completion date of October 19, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 8 mcg capsules. The $1,297.56 firm-fixed-price contract has a completion date of September 9, 2022 and was awarded on September 8, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Lubiprostone 24 MCG capsules. The contract is valued at $5,720.58 and has a completion date of February 15, 2022. AmerisourceBergen Drug Corporation is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract is not designated with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,523.23 firm-fixed-price delivery order is for 4554379657 LUBIPROSTONE 24 MCG CAPSULE 60S. There was no set-aside designation for this open competition award. The contract serves as a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT71FDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 26, 2023. The $1,672.66 firm fixed-price delivery order is for the supply of 60 units of the drug Lubiprostone 24 MCG Capsule. The contract has a performance period through May 30, 2023 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order award appears to be one of many under that broader IDC mechanism, enabling the efficient government procurement of essential medical commodities for military, veteran, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 5/26/23 |